Skip to main content
Novartis
language-selector-globe United States | en
Choose Location
  • Americas
  • Asia Pacific
  • Europe
  • International
  • Middle East & Africa
Argentina | Español
Brazil | Português
Canada | English
Canada | Français
Central America | Español
Colombia | Español
Mexico | Español
United States | English
Australia | English
Bangladesh | English
Hong Kong S.A.R. | 繁體中文
India | English
Indonesia | English
Japan | 日本語
Korea | 한국어
Mainland China | 中文
Malaysia | English
Pakistan | English
Philippines | English
Singapore | English
Taiwan | 繁體中文
Thailand | ภาษาไทย
Austria | Deutsch
Belgium | Français
Belgium | Nederlands
Bulgaria | Български
Czech Republic | Česky
Czech Republic | English
Denmark | Dansk
Estonia | Eesti
Finland | Suomalainen
France | Français
Germany | Deutsch
Greece | Ελληνικά
Hungary | Magyar
Ireland | English
Italy | Italiano
Latvia | Latvian
Lithuania | Lithuanian
Netherlands | Nederlands
Norway | Norsk
Poland | Polski
Portugal | Português
Romania | Română
Russia | Русский
Serbia | Srpski
Slovakia | Slovensky
Slovenia | Slovenščina
Slovenia | English
Spain | Español
Sweden | Svenska
Switzerland | Deutsch
Switzerland | Français
Türkiye | Türkçe
United Kingdom | English
Global | English
Novartis Foundation | English
Egypt | English
Israel | עברית
Saudi Arabia | العربية
South Africa | English
language-selector-globe us
Choose Location
Americas Asia Pacific Europe International Middle East & Africa
Argentina | Español
Australia | English
Austria | Deutsch
Bangladesh | English
Belgium | Français
Belgium | Nederlands
Brazil | Português
Bulgaria | Български
Canada | English
Canada | Français
Central America | Español
Colombia | Español
Czech Republic | Česky
Czech Republic | English
Denmark | Dansk
Egypt | English
Estonia | Eesti
Finland | Suomalainen
France | Français
Germany | Deutsch
Greece | Ελληνικά
Hong Kong S.A.R. | 繁體中文
Hungary | Magyar
India | English
Indonesia | English
Ireland | English
Israel | עברית
Italy | Italiano
Japan | 日本語
Korea | 한국어
Latvia | Latvian
Lithuania | Lithuanian
Mainland China | 中文
Malaysia | English
Mexico | Español
Netherlands | Nederlands
Norway | Norsk
Global | English
Novartis Foundation | English
Pakistan | English
Philippines | English
Poland | Polski
Portugal | Português
Romania | Română
Russia | Русский
Saudi Arabia | العربية
Serbia | Srpski
Singapore | English
Slovakia | Slovensky
Slovenia | Slovenščina
Slovenia | English
South Africa | English
Spain | Español
Sweden | Svenska
Switzerland | Deutsch
Switzerland | Français
Taiwan | 繁體中文
Thailand | ภาษาไทย
Türkiye | Türkçe
United Kingdom | English
United States | English
    • About 
      • Novartis in the US 
        • Diversity equity & inclusion  
        • Pay transparency-EPIC 
        • Our code of ethics 
      • Diversity, equity & inclusion  
        • Novartis US EEO / D&I report 2021 
        • Supplier diversity 
      • People and culture 
      • Products 
      • US Country Coordinating Committee 
      • External funding 
      • Contact us 
      Team meeting About
    • Patients and caregivers 
      • Novartis commitment to patients and caregivers 
      • Patient assistance 
      • Diseases 
        • Chronic spontaneous urticaria (CSU) 
        • Hidradenitis suppurativa (HS) 
        • Prostate Cancer (PC) 
        • Paroxysmal Nocturnal Hemoglobinuria (PNH) 
      • Participating in clinical trials 
      • Patient perspectives 
      • Adverse event reporting 
      • The STEP program 
        • Sickle cell disease (SCD) 
        • Program overview 
        • Multiple sclerosis (MS) 
        • Cancer 
        • Application for funding to help address health disparities 
        • Health disparities 
      • Patient resources 
      Patient smiling at doctor image Patients and caregivers
    • Healthcare professionals 
      • Novartis pipeline 
      • Novartis clinical trials 
      • Adverse event reporting 
      • HCP resources 
      • Personalized and Precision Medicine 
      • Health Information Technology Resources 
      Two doctors examining X-ray Healthcare professionals
    • ESG 
      • Ethical behavior 
        • Code of ethics 
        • SpeakUp 
        • PhRMA Code on interactions with healthcare professionals 
        • Business principles 
      • Ethics, risk and compliance 
        • Compliance program 
        • State laws 
        • Corporate integrity agreement 
        • Payments to HCPs & HCOs 
        • Drug Supply Chain Security Act Information 
      • Corporate responsibility 
        • Population health 
        • Novartis in society US reports 
        • Novartis US Foundation 
        • Environmental sustainability 
        • People and communities 
      • Beacon of hope 
        • Beacon of hope: Measurable solutions for health equity 
        • Paving the way for a brighter, more equitable future 
      Novartis East Hanover Campus Landscaping ESG
    • News 
      • News archive 
      • Statements 
      • Stories 
      • Contacts 
      Co-workers having a meeting News
    • Careers 
      • Career search 
      • Meet the teams 
      • Early career 
      • Personal growth 
      • How we work 
      • Employee benefits 
      • Diversity, equity & inclusion 
      • Awards & recognition 
      Meeting in Atrium Careers
    Grandmother, mother and daughter smiling and laughing on a beach Home
  1. Home
  2. Careers
  3. Career Search
  • Sort by Sort ascending
  • Job Title
  • Site Sort ascending
  • Location
  • Division
  • Business
  • Functional Area
  • Date Posted
Job Title Site Sort ascending Location Division Business Functional Area Date Posted
Senior Principal Scientist/Associate Director, Radioligand Modeling & Simulation Cambridge (USA) USA Biomedical Research Pharma Research Research & Development Sep 03, 2024
Therapeutic Area Head PKS (Global Health) Cambridge (USA) USA Biomedical Research Pharma Research Research & Development Sep 03, 2024
Compound Management, Liquid Handling Automation Operator Cambridge (USA) USA Biomedical Research Pharma Research Research & Development Sep 03, 2024
Manager, Health, Safety and Environment Cambridge (USA) USA Operations CTS Facilities & Administration Sep 04, 2024
Associate Director/Director PK Sciences - Oncology Cambridge (USA) USA Biomedical Research Pharma Research Research & Development Sep 06, 2024
Global Head Neuroscience Translational Medicine Cambridge (USA) USA Biomedical Research Pharma Research Research & Development Sep 09, 2024
Senior Scientist II/Principal Scientist I Biotransformation, PK Sciences Cambridge (USA) USA Biomedical Research Pharma Research Research & Development Oct 02, 2024
Head, Business Excellence Cambridge (USA) USA Biomedical Research Pharma Research Research & Development Oct 02, 2024
Exec. Director, Therapeutic Area Strategy, Cardiovascular Cambridge (USA) USA Strategy & Growth Innovative Medicines BD&L & Strategic Planning Oct 08, 2024
Associate Director, R&D Portfolio and Engagement - Communications Cambridge (Massachusetts) USA Corporate Affairs CTS Communications & Public Affairs Oct 08, 2024
HR Payroll and Admin Specialist - Maternity cover ~1/2years Bulgaria Bulgaria People & Organization Innovative Medicines Human Resources Oct 09, 2024
Medical Science Liaison - Solid Tumors Bucuresti Romania International Innovative Medicines Research & Development Oct 17, 2024
R2R Senior Specialist Bucuresti Romania Finance CTS Audit & Finance Sep 05, 2024
Sales Representative Onkologie (d/w/m), Gebiet: Bremen Bremen (Novartis Pharma GmbH) Germany International Innovative Medicines Sales Oct 18, 2024
Sales Representative (w/m/d), TA: Immunologie, Gebiet: Brandenburg Brandenburg (Novartis Pharma GmbH) Germany International Innovative Medicines Sales Oct 16, 2024
(高级)地区经理 Bozhou (Anhui Province) China International Innovative Medicines Sales Sep 24, 2024
(高级)地区经理 Bozhou (Anhui Province) China International Innovative Medicines Sales Sep 24, 2024
(高级)地区经理 Bozhou (Anhui Province) China International Innovative Medicines Sales Sep 24, 2024
(高级)地区经理 Bozhou (Anhui Province) China International Innovative Medicines Sales Sep 24, 2024
(高级)地区经理 Bozhou (Anhui Province) China International Innovative Medicines Sales Sep 24, 2024
(高级)地区经理 Bozhou (Anhui Province) China International Innovative Medicines Sales Sep 24, 2024
(高级)地区经理 Bozhou (Anhui Province) China International Innovative Medicines Sales Sep 24, 2024
(高级)地区经理 Bozhou (Anhui Province) China International Innovative Medicines Sales Sep 24, 2024
(高级)地区经理 Bozhou (Anhui Province) China International Innovative Medicines Sales Sep 24, 2024
(高级)地区经理 Bozhou (Anhui Province) China International Innovative Medicines Sales Sep 24, 2024
(高级)地区经理 Bozhou (Anhui Province) China International Innovative Medicines Sales Sep 24, 2024
Value Access Manager Bogota (Oncology) / Cali (Pharmaceuticals) Colombia International Innovative Medicines Market Access Oct 10, 2024
Office Manager – Public Affairs (f/m/d) Berlin West (Non-Sales Force) (Novartis Pharma GmbH) Germany Corporate Affairs Innovative Medicines Facilities & Administration Sep 02, 2024
Public Affairs Manager (m/f/d) Berlin West (Non-Sales Force) (Novartis Pharma GmbH) Germany International Innovative Medicines Communications & Public Affairs Jul 09, 2024
Senior Public Affairs Manager (m/f/d) Berlin West (Non-Sales Force) (Novartis Pharma GmbH) Germany International Innovative Medicines Market Access Sep 03, 2024
(高级)医药代表 /(资深)产品专员 Benxi (Liaoning Province) China International Innovative Medicines Sales Sep 17, 2024
(高级)地区经理 Bengbu (Anhui Province) China International Innovative Medicines Sales Oct 15, 2024
Senior/Advanced Medical/Sales Representative Beijing (Beijing) China International Innovative Medicines Sales Aug 06, 2024
MR Beijing (Beijing) China International Innovative Medicines Sales Sep 01, 2024
Senior/Advanced Medical/Sales Representative Beijing (Beijing) China International Innovative Medicines Sales Aug 06, 2024
MR Beijing (Beijing) China International Innovative Medicines Sales Sep 01, 2024
Clinical Research Associate Beijing (Beijing) China Development Innovative Medicines Research & Development Oct 09, 2024
Clinical Research Associate Beijing (Beijing) China Development Innovative Medicines Research & Development Oct 09, 2024
EA & Program Coordinator Beijing (Beijing) China Corporate Affairs Innovative Medicines Communications & Public Affairs Oct 22, 2024
MR Beijing (Beijing) China International Innovative Medicines Sales Sep 01, 2024
Clinical Research Associate Beijing (Beijing) China Development Innovative Medicines Research & Development Oct 09, 2024
Senior/Advanced Medical/Sales Representative Beijing (Beijing) China International Innovative Medicines Sales Aug 06, 2024
MR Beijing (Beijing) China International Innovative Medicines Sales Sep 01, 2024
Clinical Research Associate Beijing (Beijing) China Development Innovative Medicines Research & Development Oct 09, 2024
Senior MR Beijing (Beijing) China International Innovative Medicines Sales May 20, 2024
MR Beijing (Beijing) China International Innovative Medicines Sales Sep 03, 2024
总监助理 Beijing (Beijing) China International Innovative Medicines Sales Sep 03, 2024
Senior/Advanced Medical/Sales Representative Beijing (Beijing) China International Innovative Medicines Sales Aug 06, 2024
MR Beijing (Beijing) China International Innovative Medicines Sales Sep 01, 2024
Clinical Research Associate Beijing (Beijing) China Development Innovative Medicines Research & Development Oct 09, 2024

Pagination

  • ‹ Previous page
  • 1
  • …
  • 35
  • 36
  • 37
  • 38
  • 39
  • 40
  • 41
  • 42
  • › Next page

Novartis United States

Navigate Novartis
  • Patients & caregivers
  • Healthcare professionals
  • ESG
  • News
  • Careers
Media center
  • News archive
  • Statements
  • Stories
Our portfolio
  • Novartis clinical pipeline
  • Novartis product portfolio
Other Novartis US websites
  • Oncology HCP resources
  • Medical information
  • Global site
Footer Bottom
© 2024 Novartis Pharmaceuticals Corporation
  • Terms of use
  • Privacy policy
  • Consumer health privacy policy
  • Contacts
  • Site map
  • Web accessibility
Novartis Site Directory
This site is intended for US residents only